Mechanisms of tau- and aging-induced neurological dysfunction: Focus on the nucleus

tau 蛋白和衰老引起的神经功能障碍的机制:聚焦于细胞核

基本信息

  • 批准号:
    10343725
  • 负责人:
  • 金额:
    $ 58.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-15 至 2023-11-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The nuclear envelope is a lipid bilayer that encases the genome and provides a physical boundary between the cytoplasm and the nucleoplasm. While the nucleus is typically depicted as a sphere encircled by a smooth surface of nuclear envelope, the smooth exterior can be interrupted by tubular invaginations of the nuclear envelope into the deep nuclear interior. Such structures are termed the “nucleoplasmic reticulum.” Increased frequency of nuclear envelope invagination occurs in disease states including various cancers, viral infections, and laminopathies, a group of heterogeneous disorders that arise due to mutations in the gene encoding lamin A (LMNA). A significant increase in the frequency of nuclear envelope invaginations in the human Alzheimer’s disease (AD) brain has recently been reported. Nuclear envelope invaginations are caused by pathogenic tau, one of the two major pathological hallmarks of AD. Pathogenic tau-induced dysfunction of the lamin nucleoskeleton drives nuclear envelope invagination and causes neuronal death, demonstrating that lamin dysfunction has severe repercussions in the adult brain. These studies suggest that maintaining proper nuclear architecture is important for survival and function of adult neurons. Our preliminary studies suggest that tau- induced nuclear envelope invagination causes a toxic increase in RNA export, and that RNA quality control is compromised in tauopathy. The proposed experiments test the overall hypothesis that tau-induced nuclear envelope invaginations cause a toxic increase in RNA export that overwhelms RNA quality control machinery. The overall goals of this proposal are to 1) Define the role of tau-induced nuclear envelope invaginations on RNA export, 2) Identify the mechanism whereby genetic and pharmacologic reduction of RNA export suppress tau-induced neurotoxicity, and 3) Determine if limited clearance of RNA transcripts by nonsense-mediated RNA decay contributes to tau and age-induced neurotoxicity. We combine studies in Drosophila, induced pluripotent stem cell (iPSC)-derived neurons from AD patients, and postmortem human AD brain tissue to address causality, test hypotheses in brains of aged animals with functional neuronal networks, and determine relevance to human AD. If our hypothesis is correct, a model will emerge that puts the lamin nucleoskeleton, nuclear envelope, and RNA handling at the central interface between aging and tauopathy. We anticipate that a multi-system investigation into the repercussions of nuclear envelope invagination will have a major impact on disorders involving nuclear architecture disruption beyond AD, aging and related tauopathies, and could lead to future development of novel, mechanism-based therapies.
项目摘要 核包膜是一种脂质双层,它包围了基因组,并在 细胞质和核质。而核通常被描述为一个被平滑环绕的球体 核包膜的表面,光滑的外部可以被核的管状内幕中断 封底进入深核内部。这种结构称为“核质网”。增加 核包膜的频率发生在包括各种癌症,病毒感染的疾病状态中, 和椎板病,这是一组由于编码层粘连蛋白的突变引起的异质性疾病 A(LMNA)。人类阿尔茨海默氏症中核包膜起伏的频率显着增加 疾病(AD)大脑最近有报道。核包络起伏是由致病性tau引起的 AD的两个主要病理标志之一。致病性tau诱导的层粘连功能障碍 核骨骼驱动核包膜创新并导致神经元死亡,表明层粘连蛋白 功能障碍在成人大脑中产生严重影响。这些研究表明,保持适当的核 建筑对于成人神经元的生存和功能很重要。我们的初步研究表明tau- 诱导的核包膜的内陷导致RNA导出的毒性增加,RNA质量控制是 在tauopathy中受到妥协。提出的实验检验了tau诱导的核的总体假设 包络起伏会导致RNA导出的有毒增加,使RNA质量控制机制不堪重负。 该提案的总体目标是1)定义tau引起的核包络创新在 RNA导出,2)确定RNA导出遗传和药物提取的机制 TAU诱导的神经毒性,3)确定无义介导的RNA转录本是否有限 RNA衰减有助于TAU和年龄引起的神经毒性。我们结合了果蝇的研究,诱导 来自AD患者的多能干细胞(IPSC)衍生的神经元,并在死后人类AD脑组织到 解决因果关系,具有功能性神经元网络的老年动物大脑的检验假设,并确定 与人类广告有关。如果我们的假设是正确的,则会出现一个模型,将层粘连核骨骨骼呈现为 核包膜,以及在衰老和tauopathy之间的中央界面处的RNA处理。我们预料到这一点 对核信封内部影响的影响的多系统调查将产生重大影响 关于涉及广告,衰老和相关tauopath的核建筑中断的疾病,并且可以 导致基于机制的新型疗法的未来发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bess Frost其他文献

Bess Frost的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bess Frost', 18)}}的其他基金

Mechanisms of tau- and aging-induced neurological dysfunction: Focus on the nucleus
tau 蛋白和衰老引起的神经功能障碍的机制:聚焦于细胞核
  • 批准号:
    10532781
  • 财政年份:
    2019
  • 资助金额:
    $ 58.37万
  • 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
  • 批准号:
    9380979
  • 财政年份:
    2015
  • 资助金额:
    $ 58.37万
  • 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
  • 批准号:
    9189742
  • 财政年份:
    2015
  • 资助金额:
    $ 58.37万
  • 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
  • 批准号:
    9173275
  • 财政年份:
    2015
  • 资助金额:
    $ 58.37万
  • 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
  • 批准号:
    8904739
  • 财政年份:
    2014
  • 资助金额:
    $ 58.37万
  • 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
  • 批准号:
    8760586
  • 财政年份:
    2014
  • 资助金额:
    $ 58.37万
  • 项目类别:
Tau-mediated chromatin regulation and neurodegeneration
Tau 介导的染色质调节和神经退行性变
  • 批准号:
    8319393
  • 财政年份:
    2010
  • 资助金额:
    $ 58.37万
  • 项目类别:
Tau-mediated chromatin regulation and neurodegeneration
Tau 介导的染色质调节和神经退行性变
  • 批准号:
    8061231
  • 财政年份:
    2010
  • 资助金额:
    $ 58.37万
  • 项目类别:
Tau-mediated chromatin regulation and neurodegeneration
Tau 介导的染色质调节和神经退行性变
  • 批准号:
    8197962
  • 财政年份:
    2010
  • 资助金额:
    $ 58.37万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
  • 批准号:
    10642368
  • 财政年份:
    2023
  • 资助金额:
    $ 58.37万
  • 项目类别:
Perspectives of Correctional Officers about Older Adults in Prison: A Grounded Theory Study
惩教人员对监狱中老年人的看法:扎根理论研究
  • 批准号:
    10749275
  • 财政年份:
    2023
  • 资助金额:
    $ 58.37万
  • 项目类别:
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
  • 批准号:
    10584712
  • 财政年份:
    2023
  • 资助金额:
    $ 58.37万
  • 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
  • 批准号:
    10755205
  • 财政年份:
    2023
  • 资助金额:
    $ 58.37万
  • 项目类别:
3D force sensing insoles for wearable, AI empowered, high-fidelity gait monitoring
3D 力传感鞋垫,用于可穿戴、人工智能支持的高保真步态监控
  • 批准号:
    10688715
  • 财政年份:
    2023
  • 资助金额:
    $ 58.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了